BRENTUXIMAB for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where BRENTUXIMAB was used for Product used for unknown indication.
Most Reported Side Effects for BRENTUXIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 40 | 22.2% | 13 | 21 |
| Drug ineffective | 30 | 16.7% | 7 | 9 |
| Disease progression | 23 | 12.8% | 6 | 2 |
| Febrile neutropenia | 14 | 7.8% | 0 | 9 |
| Malignant neoplasm progression | 13 | 7.2% | 7 | 7 |
| Neuropathy peripheral | 10 | 5.6% | 0 | 5 |
| Product use in unapproved indication | 9 | 5.0% | 2 | 5 |
| Tubulointerstitial nephritis | 9 | 5.0% | 0 | 8 |
| Acute kidney injury | 8 | 4.4% | 1 | 8 |
| Pancytopenia | 8 | 4.4% | 1 | 6 |
| Sepsis | 8 | 4.4% | 4 | 3 |
| Vomiting | 8 | 4.4% | 1 | 5 |
| C-reactive protein increased | 7 | 3.9% | 0 | 6 |
| Covid-19 | 7 | 3.9% | 4 | 6 |
| Disease recurrence | 7 | 3.9% | 0 | 0 |
Other Indications for BRENTUXIMAB
Hodgkin's disease (61)
Diffuse large b-cell lymphoma (18)
Cutaneous t-cell lymphoma (15)
Chemotherapy (10)
Anaplastic large cell lymphoma t- and null-cell types (9)
Hodgkin's disease recurrent (8)
Adult t-cell lymphoma/leukaemia (6)
Non-hodgkin's lymphoma (5)
Primary mediastinal large b-cell lymphoma recurrent (5)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)